Bio-Techne (TECH) Current Deferred Tax Assets (2010 - 2015)
Bio-Techne (TECH) posted quarterly Current Deferred Tax Assets of $11.5 million for Q4 2015, down 12.05% year-over-year from $13.1 million in Q4 2014, and down 30.96% quarter-over-quarter from $16.7 million in Q3 2015.
Bio-Techne (TECH) Current Deferred Tax Assets (2010 - 2015) Analysis & Trends
Bio-Techne's Current Deferred Tax Assets history runs 5 years deep, the most recent figure standing at $11.5 million for Q4 2015.
- In Q4 2015, Current Deferred Tax Assets fell 12.05% year-over-year to $11.5 million; the TTM figure through Dec 2015 stood at $11.5 million (down 12.05% YoY), while the FY2015 annual figure was $11.5 million, up 19.62% from the prior year.
- Current Deferred Tax Assets for Q4 2015 stood at $11.5 million, down from $16.7 million in the prior quarter.
- The five-year high for Current Deferred Tax Assets was $19.1 million in Q3 2014, with the low at $5.8 million in Q2 2011.
- The 4-year median for Current Deferred Tax Assets is $11.2 million (2011), against an average of $11.2 million.
- The sharpest annual moves came in 2011 and 2014: Current Deferred Tax Assets plunged 56.67% in 2011, then jumped 100.99% in 2014.
- Bio-Techne's Current Deferred Tax Assets stood at $12.9 million in 2011, then slipped by 23.55% to $9.9 million in 2013, then jumped by 32.52% to $13.1 million in 2014, then declined by 12.05% to $11.5 million in 2015.
- Business Quant data shows TECH's Current Deferred Tax Assets at $11.5 million in Q4 2015, $16.7 million in Q3 2015, and $11.5 million in Q2 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Bio-Techne | 11.33 Bn | 11.12 Bn | 208.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2015 | 11.51 Mn |
| Dec 31, 2015 | 11.51 Mn |
| Sep 30, 2015 | 16.68 Mn |
| Sep 30, 2015 | 16.68 Mn |
| Jun 30, 2015 | 11.51 Mn |
| Jun 30, 2015 | 11.51 Mn |
| Mar 31, 2015 | 11.73 Mn |
| Mar 31, 2015 | 11.73 Mn |
| Dec 31, 2014 | 13.09 Mn |
| Dec 31, 2014 | 13.09 Mn |
| Sep 30, 2014 | 19.15 Mn |
| Sep 30, 2014 | 19.15 Mn |
| Jun 30, 2014 | 9.62 Mn |
| Jun 30, 2014 | 9.62 Mn |
| Mar 31, 2014 | 8.51 Mn |
| Mar 31, 2014 | 8.51 Mn |
| Dec 31, 2013 | 9.88 Mn |
| Dec 31, 2013 | 9.88 Mn |
| Sep 30, 2013 | 9.53 Mn |
| Sep 30, 2013 | 9.53 Mn |